Substance / Medication

Estrone

Overview

Active Ingredient
estrone
RxNorm CUI
4103

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

78 trials linked to this intervention

78
Total Trials
14
Recruiting
23
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Urinary 2- to 16α-hydroxyestrone ratio did not change with cruciferous vegetable intake in premenopausal women.
Davis Stephanie J, Arscott Sara A, Goltz Shellen et al. · Int J Vitam Nutr Res · 2024
PMID: 37335576RCT
High circulating oestrone and low testosterone correlate with adverse clinical outcomes in men with advanced liver disease.
Sinclair Marie, Gow Paul J, Angus Peter W et al. · Liver Int · 2016
PMID: 26998685RCT
Alterations in luteal production of androstenedione, testosterone, and estrone, but not estradiol, during mid- and late pregnancy in pigs: effects of androgen deficiency.
Grzesiak Malgorzata, Knapczyk-Stwora Katarzyna, Ciereszko Renata E et al. · Theriogenology · 2014
PMID: 25011982RCT
CYP3A variation, premenopausal estrone levels, and breast cancer risk.
Johnson Nichola, Walker Kate, Gibson Lorna J et al. · J Natl Cancer Inst · 2012
PMID: 22472546RCT
Soy protein isolate increases urinary estrogens and the ratio of 2:16alpha-hydroxyestrone in men at high risk of prostate cancer.
Hamilton-Reeves Jill M, Rebello Salome A, Thomas William et al. · J Nutr · 2007
PMID: 17885008RCT
Comparison of leptin and estrone levels between normal body mass index and obese menopausal women.
Siregar Muhammad Fg, Terauchi Masakazu, Sari Rizka A et al. · Narra J · 2024
PMID: 39280324ObservationalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Estrone (substance)
SNOMED CT
51775003
UMLS CUI
C0014942
RxNorm CUI
4103

Clinical Data

This intervention maps to 13 entities in the Healos knowledge graph.

7
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
78
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Estrone — Conditions, Biomarkers & Specialists | Healos | Ltrl